Factors Affecting the Prognosis of Early Ovarian Cancer
NCT04414683 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-09-15
Summary
To elucidate factors affecting survival of early stage ovarian cancer
Conditions
Interventions
- PROCEDURE
-
staging surgery
laparoscopic or laparotomic staging surgery
Sponsors & Collaborators
-
Far Eastern Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-13
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
NCT00626873 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
NCT02686463 ·Status: UNKNOWN ·Phase: NA
-
Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer
NCT04135521 ·Status: COMPLETED
-
Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
NCT06535334 ·Status: NOT_YET_RECRUITING
-
Survival Outcomes of Ovarian Malignancies in Chinese Population
NCT03291262 ·Status: UNKNOWN
-
Appraising Medical Trial Experiences of Ovarian Cancer Patients
NCT05801796 ·Status: NOT_YET_RECRUITING
-
Lymphadenectomy in Early Ovarian Cancer
NCT04710797 ·Status: RECRUITING ·Phase: NA
-
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
NCT06468254 ·Status: RECRUITING ·Phase: PHASE2
-
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
NCT03491033 ·Status: COMPLETED
-
The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
NCT03019315 ·Status: UNKNOWN
-
Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence
NCT06237946 ·Status: NOT_YET_RECRUITING
-
Ovarian Clear Cell Adenocarcinoma Review
NCT02129036 ·Status: COMPLETED
-
Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer
NCT06640348 ·Status: RECRUITING
-
Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer
NCT06574763 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Improving Quality of Care for Patients With Recurrent Ovarian Cancer
NCT02809339 ·Status: UNKNOWN
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients
NCT06182917 ·Status: RECRUITING
-
Microtransplantation for Ovarian Cancer
NCT05095558 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer
NCT03692637 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment
NCT05274867 ·Status: UNKNOWN
-
MRI in Staging Ovarian Cancer Using MRI Contrast Agent
NCT00463996 ·Status: UNKNOWN
-
Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer
NCT06395844 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer
NCT06120309 ·Status: ENROLLING_BY_INVITATION
-
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
NCT01074398 ·Status: UNKNOWN
-
Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study
NCT02291276 ·Status: WITHDRAWN